| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/22/1989 | EP0308381A1 Artificial gene coding for authentic human serum albumin, use thereof, and method of producing the same |
| 03/22/1989 | EP0308378A2 Tumor necrosis factor (TNF)inhibitory protein and its purification |
| 03/22/1989 | EP0308336A2 Process for the production of human pro-apolipoprotein A-I-like proteins |
| 03/22/1989 | EP0308199A1 Bacillus thuringiensis toxin |
| 03/22/1989 | EP0308067A2 Alpha-amidating enzyme compositions and processes for their production and use |
| 03/22/1989 | EP0307858A2 The SM-B/B1 antigens, the cloning of the SM-B/B1 antigens and the detection of systemic lupus erythematosus by using the SM-B/B1 antigens |
| 03/22/1989 | EP0307754A2 Method for obtaining a papain-free antibody fragment preparation |
| 03/22/1989 | EP0307592A2 Analogues of the pancreatic bovine trypsin inhibitor, their production and use |
| 03/22/1989 | EP0307513A2 Pulmonary hydrophobic surfactant-associated proteins |
| 03/22/1989 | EP0307476A1 Bilirubin antigen, monoclonal antibody therefor, process for their preparation, and their use |
| 03/21/1989 | US4814433 Method for obtaining a papain-free antibody fragment preparation |
| 03/15/1989 | EP0307248A2 Method for increasing the expression of polypeptides in recombinant cell culture |
| 03/15/1989 | EP0307247A2 A method for culturing recombinant cells |
| 03/15/1989 | EP0307186A2 Anti-ganglioside GD1a monoclonal antibody MZ, MZ-producing cells and MZ-containing reagent |
| 03/15/1989 | EP0307149A2 Solid phase immunoassay for an antibody and biological constructions for use therein |
| 03/15/1989 | EP0306995A2 Tumor immunotherapy using anti-idiotypic antibodies |
| 03/15/1989 | EP0306985A2 Bacteriorhodopsin modifications and methods for their preparation |
| 03/15/1989 | EP0306968A2 Process for producing recombinant human factor VIII:C |
| 03/15/1989 | EP0306870A2 Gamma-interferon derivatives, process for their manufacture, vectors and medicines obtained therefrom |
| 03/15/1989 | EP0306848A1 Expression vector and method for the expression of heterologous proteins in mammalian cells |
| 03/15/1989 | EP0306680A2 Monoclonal antibodies to anti-thrombin binding substance, and their uses |
| 03/15/1989 | EP0306673A1 A method for the preparation of human growth hormone |
| 03/15/1989 | EP0306645A2 Teicoplanin-like derivatives |
| 03/15/1989 | EP0306610A1 Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase |
| 03/14/1989 | US4812559 Vaccine against varicella-zoster virus |
| 03/14/1989 | US4812441 Hypocholesterolemically active protein derived from streptococcus |
| 03/14/1989 | CA1251153A1 Preparation of peptides with c-terminal proline amide |
| 03/09/1989 | WO1989001978A1 Specific dna molecular probes for bos-type male genome |
| 03/09/1989 | WO1989001976A1 Recombinant dna-derived bordetella toxin subunit analogs |
| 03/09/1989 | WO1989001975A1 Recombinant antibodies and methods for their production |
| 03/09/1989 | WO1989001974A1 Recombinant antibody |
| 03/09/1989 | WO1989001969A1 Process for the production of protein products in aspergillus and promoters for use in aspergillus |
| 03/09/1989 | WO1989001968A1 Aprotinin homologues and process for the production of aprotinin and aprotinin homologues in yeast |
| 03/09/1989 | WO1989001947A1 Protein derived from living body |
| 03/09/1989 | WO1989001946A1 Biological materials, processes for producing biological materials and for using such materials in therapy |
| 03/09/1989 | WO1989001945A1 Follistatin and method of purifying same |
| 03/09/1989 | WO1989001940A1 Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins |
| 03/09/1989 | WO1989001783A2 Recombinant antibody and method |
| 03/09/1989 | WO1989001782A1 Recombinant antibody |
| 03/09/1989 | WO1989001773A1 Synovial phospholipases |
| 03/08/1989 | EP0306470A1 DNA molecules encoding bovine placental lactogen peptide and pre-peptide and genetically transformed cells comprising these molecules |
| 03/08/1989 | EP0306318A1 Recombinant DNA-derived bordetella toxin subunit analogs |
| 03/08/1989 | EP0306219A2 Novel HIV proteins and peptides useful in the diagnosis, prophylaxis or therapy of AIDS |
| 03/08/1989 | EP0305960A2 A transformant cell line capable of producing a human monoclonal antibody, hybridoma, their production and use |
| 03/08/1989 | EP0305777A2 Synthesis of human immunodeficiency virus type 1 antigens and their use as diagnostic and therapeutic agents |
| 03/08/1989 | EP0305760A2 Method of isolating basic proteins from a protein mixture |
| 03/08/1989 | EP0305500A1 Process for the purification of recombinant polypeptides. |
| 03/07/1989 | US4810817 Artificial sweeteners |
| 03/07/1989 | US4810780 Protein having phospholipase A2 inhibitory activity |
| 03/07/1989 | US4810692 Cyclodeposipeptides |
| 03/07/1989 | US4810643 Production of pluripotent granulocyte colony-stimulating factor |
| 03/07/1989 | US4810492 Vaccine against japanese encephalitis |
| 03/07/1989 | US4810491 Polypeptides useful in vaccination against enteroviruses |
| 03/01/1989 | EP0305279A1 Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
| 03/01/1989 | EP0305278A1 Adjuvants for the production and culture of hybridomas |
| 03/01/1989 | EP0305229A1 Viral vector and recombinant DNA encoding one or more structural proteins (HA,F and/or NP) of a morbillivirus |
| 03/01/1989 | EP0305087A1 Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors |
| 03/01/1989 | EP0305063A2 A process for production of c-terminal alpha-amide peptides |
| 03/01/1989 | EP0304486A1 Production of bioadhesive precursor protein analogs by genetically-engineered organisms |
| 03/01/1989 | EP0304481A1 Monoclonal antibodies produced against glomerular proteoglycans |
| 03/01/1989 | CN1031396A New toxin-encoding dna fragments from bacillus thuringiensis subsp, israellensis |
| 03/01/1989 | CN1031395A Hepatitis b virus surface antigens and hybrid antigens containing them |
| 02/28/1989 | US4808700 Vaccine for immunization of young mammals against infections |
| 02/28/1989 | US4808536 Human t-cell lymphotropic virus; acquired immunodeficiency syndrome; in kit form; screening |
| 02/28/1989 | CA1250524A1 Preparation and use of enzyme-detergent extracted streptococcus equi vaccine |
| 02/23/1989 | WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 02/23/1989 | WO1989001628A1 Monoclonal antibodies reactive with cytomegalovirus glycoprotein a |
| 02/23/1989 | WO1989001520A1 Procaryotic xylose isomerase muteins and method to increase protein stability |
| 02/23/1989 | WO1989001519A1 Human mannose binding protein |
| 02/23/1989 | WO1989001518A1 Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors |
| 02/23/1989 | WO1989001517A1 Vector for integration site independent gene expression in mammalian host cells |
| 02/23/1989 | WO1989001514A1 Molecular cloning of human rotavirus serotype 4 gene 9 encoding vp7, the major outer capsid neutralisation specific glycoprotein and expression of vp7 and fragments thereof for use in a vaccine |
| 02/23/1989 | WO1989001490A2 Biologically active molecules |
| 02/23/1989 | WO1989001486A1 Biologically active bactericidal/permeability-increasing protein fragments |
| 02/23/1989 | WO1989001337A1 Methods and compositions for mimicking antigenic determinants |
| 02/23/1989 | WO1989000582A3 Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 02/22/1989 | EP0304329A2 Monoclonal antibodies and hybridomas and sensitized cells for HBs antigen assay |
| 02/22/1989 | EP0304311A1 Complex of polyethylene glycol and tissue plasminogen activator |
| 02/22/1989 | EP0304178A1 Fungicidal toxin and method and inoculum for controlling root rot and damping off |
| 02/22/1989 | EP0303972A2 Expression plasmids containing the deo promoter, and bacterial hosts containing the plasmids |
| 02/22/1989 | EP0303925A1 High repressible sequence for control of expression |
| 02/22/1989 | EP0303859A2 Cloning of DNA encoding antibacterial polypeptide precursor and expression of the precursor |
| 02/22/1989 | EP0303692A1 Cloning of lfa-1 |
| 02/22/1989 | EP0303668A1 Stable expression vectors |
| 02/22/1989 | EP0303602A1 Enzymatic synthesis |
| 02/22/1989 | EP0200767A4 Sandwich immunoassay of antigens involved in ophthalmic disorders. |
| 02/22/1989 | CN1031229A Process for preporing 1.5-benzothiazepine eerivatives |
| 02/21/1989 | US4806492 Polypeptide tumor inhibitors and antibodies thereto |
| 02/21/1989 | US4806473 Using carboxypeptidase y to cleave protective groups; producing di-, tri- and tetrapeptides |
| 02/21/1989 | US4806347 Antitumor agents, viricides in humans |
| 02/15/1989 | EP0303540A1 Factor VIII analog, process for its preparation and composition containing it |
| 02/15/1989 | EP0303538A2 Protein with a vascular activity, derived from monocytes and its analogues, process for its extraction and their uses as therapeutic agents and for the preparation of antibodies |
| 02/15/1989 | EP0303488A2 Biologically active molecules |
| 02/15/1989 | EP0303483A2 Novel lymphokine and compositions thereof |
| 02/15/1989 | EP0303463A2 Method to control leukocyte extravasation |
| 02/15/1989 | EP0303329A1 A process for isolating coagulation factors, and adsorbent material suitable therefor |
| 02/15/1989 | EP0303309A2 A genus-specific Listeria antigen identified by monoclonal antibodies |
| 02/15/1989 | EP0303233A2 Human reg protein |
| 02/15/1989 | EP0303088A2 Purified IgM |
| 02/15/1989 | EP0303033A2 Molecular cloning and characterization of a further gene sequence coding for human relaxin |